Navigation Links
Ardelyx to Present at the Wedbush 2014 Life Sciences Management Access Conference
Date:8/5/2014

FREMONT, Calif., Aug. 5, 2014 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a clinical-stage biopharmaceutical company focused on cardio-renal, GI and metabolic diseases, today announced that Mike Raab, Ardelyx's President and Chief Executive Officer, is scheduled to present at the Wedbush 2014 Life Sciences Management Access Conference on Tuesday, August 12, 2014, at 2:30pm Eastern Time at the Le Parker Meridien Hotel in New York City. 

Individuals who are interested in listening to the live presentation can participate via webcast at http://wsw.com/webcast/wedbush28/ardx. A copy of the presentation will also be available at http://www.ardelyx.com.

About Ardelyx, Inc.

Ardelyx is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative, non-systemic, small molecule therapeutics that work exclusively in the gastrointestinal tract to treat cardio-renal, gastrointestinal and metabolic diseases. The Company has developed a proprietary drug discovery and design platform enabling it, in a rapid and cost-efficient manner, to discover and design novel drug candidates. Utilizing this platform, Ardelyx has discovered and designed tenapanor, a product currently in three separate Phase 2 clinical trials for the treatment of constipation-predominant irritable bowel syndrome (IBS-C), complications associated with end-stage renal disease (ESRD), and chronic kidney disease (CKD).

Ardelyx formed a collaborative partnership with AstraZeneca in October 2012 to develop and commercialize tenapanor. In addition to tenapanor, the Company is evaluating small molecule NaP2b inhibitors for the treatment of hyperphosphatemia in ESRD, a program licensed to Sanofi, and
'/>"/>

SOURCE Ardelyx, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Intrexon to Present at Jefferies 2014 Global Industrials Conference
2. Selexis SA to Present New Data and a Case Study at IBC’s Cell Line Development and Engineering Conference
3. TransVac Presents Cost Saving Technology at ASHE Conference for Keeping Hospitals Cleaner
4. Dmitry Medvedev Presented BIOCAD the First National "Industry" Award
5. Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness"
6. Neuralstem President And CEO To Present 2014 Trials Overview At 2014 Biotech Showcase
7. MiMedx to Present at 32nd Annual J.P. Morgan Healthcare Conference
8. Spherix Secures License For CompuFill Patents - Agreement Represents Spherix Second License Agreement Under New License Campaign
9. New Technology and Healthcare Environment Present Both Challenges and Opportunities for Pharmaceutical Call Centers
10. Halozyme Therapeutics To Present At The 32nd Annual J.P. Morgan Healthcare Conference
11. Generex Announces Selection of Antigen Express Technology for Keynote Presentation at 2014 TIDES Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015  Actavis plc (NYSE: ACT ... Court of Appeals for the Second Circuit has issued ... requiring the Company to continue distribution of NAMENDA ® ... http://photos.prnewswire.com/prnh/20130124/NY47381LOGO   "While we are ... we intend to continue our strong efforts to convey ...
(Date:5/22/2015)... May 22, 2015 Baylor Research Institute (BRI) ... Translational Genomics Research Institute (TGen) in Phoenix, ... on accelerating early detection and treatments for patients with a ... institutions will lead to new clinical trials and access to ... the gap from bench to bedside across Baylor Scott ...
(Date:5/21/2015)... 2015  Susan Hedstrom, Executive Director of the ... dedicated to supporting research to advance the understanding ... that FPWR has received the organization,s largest donation ... contributed $1 million in support of the organization,s ... "Our gift signifies our tremendous ...
(Date:5/21/2015)... Imagine being able to probe and truly ... Being able to read faces and enjoy genuine invisible ... their thoughts and actions like never before. Use ... unique abstract paintings and video, or, play a completely ... as it creates action, dialog, and outcomes based on ...
Breaking Biology Technology:Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 2Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 3Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 4Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 5Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 6Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 7Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 8Precision Medicine Collaboration to Increase Options for Cancer Patients 2Precision Medicine Collaboration to Increase Options for Cancer Patients 3Precision Medicine Collaboration to Increase Options for Cancer Patients 4The Foundation for Prader-Willi Research Receives $1M Contribution in Support of Clinical Initiatives 25 Days to Meet ARGUS - The World's First Contactless Emotions Scanner 2
... Robust Amplification of Partially Degraded RNA, ... today announced the launch of its TransPlex(R) ... TransPlex,technology is believed to be the fastest, ... total RNA from a variety of sample ...
... CITY, Mo., Oct. 27 Thomas Reidy, an investor ... developer and,manufacturer of diagnostic products whose American Depository Receipts ... November 3, 2008,at 10:00am EST, to discuss the recent ... Biotech,s current directors., On October 16, 2008, Mr. ...
... - Teva Announces Sufficient Funds to Complete Acquisition, ... Industries Ltd. (Nasdaq: TEVA ) and Barr,Pharmaceuticals, Inc. ... its,syndicate of lending banks, arranged by Bank of America, ... them to remain in place,following Barr,s acquisition by Teva., ...
Cached Biology Technology:Sigma-Aldrich Releases WTA2, a Transplex Whole Transcriptome Amplification Technology for Degraded RNA Samples 2Investor Call Scheduled to Discuss Ouster Proposal of Trinity Biotech Directors 2Teva and Barr Provide Update on Acquisition 2Teva and Barr Provide Update on Acquisition 3Teva and Barr Provide Update on Acquisition 4Teva and Barr Provide Update on Acquisition 5
(Date:5/19/2015)... 19, 2015 Research ... addition of the  "Genetic Testing Market Outlook ... http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent report, Genetic Testing ... of the current and future genetic testing ... their working principles and types are covered ...
(Date:5/14/2015)... NEW YORK , May 14, 2015 ... specializing in identity verification and online remote ... Instructure, a software-as-a-service (SaaS) company and creator ... Shared customers of the two companies will ... Proctortrack in Canvas. As a ...
(Date:5/11/2015)... May 11, 2015 Curemark LLC, a privately ... of a new Phase III double blind, randomized, placebo-controlled ... formulation, CM-AT, on all children ages 3-8 with Autism. ... Phase III double blinded clinical trial for CM-AT in ... of the digestive enzyme chymotrypsin. This new trial will ...
Breaking Biology News(10 mins):Global Genetic Testing Market Outlook 2018 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2
... Society and the Zoological Society of London has found that ... promiscuity in the animal kingdom is generally a male thing, ... of London (ZSL) have found that, in cheetah society, it’s ... paper in the latest issue of Proceedings of the Royal ...
... copying the body’s own natural "waste disposal" chemistry to mop ... of patients with urea cycle disorders --- most of them ... England Journal of Medicine summarizing a quarter century of experience ... and sodium benzoate, two chemicals the body already makes to ...
... of a smallpox outbreak in the United States, how long ... to start protecting Americans by stimulating an immune response? ... School of Medicine will attempt to answer this question. ... United States in 1971, and the world was declared free ...
Cached Biology News:Philandering female felines forgo fidelity 2An 'elegant' idea proves its worth 25 years later 2Smallpox outbreak: How long would it take for vaccines to protect people? Would it work? 2
Latanoprost EIA Antiserum EIAs neutrophils antisera enzyme immunoassays reagents...
Zinc finger MYM-type protein 3 (Zinc finger protein 261) (DXS6673E protein). [Source:Uniprot/SWISSPROT;Acc:Q14202] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Phospho-SEK1/MKK4 (Thr261) Antibody...
Human Ig Lambda-chain, clone ICO-16, Monoclonal Antibody...
Biology Products: